Thromboembolic disease in systemic vasculitis is associated with enhanced microparticle-mediated thrombin generation

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 9, 2011, Pages 1864-1867

  Eleftheriou, D ^a   Hong, Y ^a   Klein, N J ^a   Brogan, P A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; THROMBIN;

ANTICOAGULANT THERAPY; APOPTOSIS; ARTERIOGRAPHY; BLOOD ANALYSIS; CELL ACTIVATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LETTER; MAGNETIC RESONANCE ANGIOGRAPHY; MEDIATOR; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLATELET MICROPARTICLE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROPHYLAXIS; PROTHROMBIN TIME; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC VASCULITIS; THROMBIN TIME; THROMBOEMBOLISM; THROMBOPHILIA; WEGENER GRANULOMATOSIS;

ADOLESCENT; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; SYSTEMIC VASCULITIS; THROMBIN; THROMBOEMBOLISM;

EID: 80052422572     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04434.x     Document Type: Letter

References (18)

1. Merkel PA, Lo GH, Holbrook JT, Tibbs AK, Allen NB, Davis JC, Hoffman GS, McCune WJ, St ClairEW, Specks U. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med 2005; 142: 620.
2. Tomasson G, Monach PA, Merkel PA. Thromboembolic disease in vasculitis. Curr Opin Rheumatol 2009; 21: 41.
3. Sebastian JK, Voetsch B, Stone JH, Romay-Penabad Z, Lo GH, Allen NB, Davis JC, Hoffman GS, McCune WJ, St Clair EW. The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event. J Rheumatol 2007; 34: 2446.
4. Weidner S, Hafezi-rachti S, Rupprecht HD. Thromboembolic events as a complication of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res 2006; 55: 146-9.
5. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110: 2747.
6. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, gnat-George F, Freyssinet JM. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 2006; 26: 2594.
7. Leroyer AS, Anfosso F, Lacroix R, Sabatier F, Simoncini S, Njock SM, Jourde N, Brunet P, Camoin-Jau L, Sampol J. Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thromb Haemost 2010; 104: 456-63.
8. Brogan PA, Shah V, Brachet C, Harnden A, Mant D, Klein N, Dillon MJ. Endothelial and platelet microparticles in vasculitis of the young. Arthritis Rheum 2004; 50: 927-36.
9. Clarke LA, Hong Y, Eleftheriou D, Shah V, Arrigoni F, Klein NJ, Brogan PA. Endothelial injury and repair in systemic vasculitis of the young. Arthritis Rheum 2010; 62: 1770-80.
10. Brogan PA, Davies R, Gordon I, Dillon MJ. Renal angiography in children with polyarteritis nodosa. Pediatr Nephrol 2002; 17: 277-83.
11. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 2010; 69: 798-806.
12. Criteria for diagnosis of Behcet's disease. International study group for Behcet's disease. Lancet 1990; 335: 1078-80.
13. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM. Nomenclature of systemic vasculitides. Arthritis Rheum 1994; 37: 187-92.
14. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D. Birmingham vasculitis activity score (BVAS) Dim system necrotizinig vasculitis. QJM 1994; 87: 671.
15. Clarke LA, Shah V, Arrigoni F, Eleftheriou D, Hong Y, Halcox J, Klein N, Brogan PA. Quantitative detection of circulating endothelial cells in vasculitis: comparison of flow cytometry and immunomagnetic bead extraction. J Thromb Haemost 2008; 6: 1025-32.
16. Bidot L, Jy W, Bidot C Jr, Jimenez JJ, Fontana V, Horstman LL, Ahn YS. Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis. J Thromb Haemost 2008; 6: 913-9.
17. Gardner-Medwin JMM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002; 360: 1197-202.
18. Hong Y, Eleftheriou D, Savage C, Hussain A, Klein NJ, Brogan PA. ANCA induced microparticles in the pathogenesis of ANCA associated vasculitides. Clin Exp Immunol 2011; 164: 134.